# US 2025/0059203 A1 · Use of aristoloxazine c having anticancer activity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0059203 A1
- Document ID: US20250059203A1
- Status: Published application
- Kind: A1
- Application number: 18/723,290
- Filed: 2022-12-21
- Published: 2025-02-20
- Earliest claimed: 2021-12-21
- Assignees: Korea Institute of Oriental Medicine
- Applicants: Korea Institute of Oriental Medicine
- Inventors: Jun LEE; Young Hye SEO; Byeong Cheol MOON; A Yeong LEE; Seung Mok RYU; Hyo Seon KIM
- Web page: https://patentgrep.com/patent/US20250059203A1

## CPC

- C07D 498/04: Ortho-condensed systems
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 31/536: ortho- or peri-condensed with carbocyclic ring systems
- A61K 31/5365: ortho- or peri-condensed with heterocyclic ring systems
- A61K 36/268: Asarum (wild ginger)
- A61P 35/00: Antineoplastic agents
- A61K 2121/00: Preparations for use in therapy
- A61K 2236/33: involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K 2236/333: using mixed solvents, e.g. 70% EtOH
- A61K 2236/35: Extraction with lipophilic solvents, e.g. Hexane or petrol ether
- A61K 2236/39: Complex extraction schemes, e.g. fractionation or repeated extraction steps
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to an anticancer use of aristoloxazine C, and more specifically to a pharmaceutical composition and a health functional food composition which use aristoloxazine C represented by Chemical Formula 1 or an isomer or pharmaceutically acceptable salt thereof, a method for preventing, ameliorating or treating cancer by using same; and a method for isolating aristoloxazine C.

## Claims

### Claim at position 1

1-8. (canceled)

### Claim 9

A method for isolating aristoloxazine C represented by Chemical Formula 1 from Asarum heterotropoides roots, comprising the steps of:
(a) extracting Asarum heterotropoides roots with an ethanol solvent to obtain an ethanol extract of the Asarum heterotropoides roots;
(b) obtaining an ethyl acetate fraction by systematically fractionating the ethanol extract of the Asarum heterotropoides roots in the order of hexane, ethyl acetate and water;
(c) performing flash chromatography on the ethyl acetate fraction by using a water-methanol mixture as an effluent solvent to obtain a fraction; and
(d) purifying the aristoloxazine C by subjecting the fraction obtained after performing column chromatography to semi-preparative chromatography by using a water-acetonitrile mixture as an effluent solvent.

### Claim 10 (depends on 9)

The method of claim 9, wherein the ethanol solvent in step (a) is 50 to 90% ethanol.

### Claim 11 (depends on 9)

The method of claim 9, wherein the water-methanol mixture in step (c) is applied at a concentration gradient of 6:4 to 1:9.

### Claim 12 (depends on 9)

The method of claim 9, wherein the water-acetonitrile mixture in step (d) is applied at a concentration gradient of 6.5:3.5 to 5.5:4.5.

### Claim 13

A method for preventing, ameliorating or treating cancer, comprising the step of administering aristoloxazine C represented by Chemical Formula 1, an isomer or a pharmaceutically acceptable salt thereof to a subject in need thereof:

### Claim 14 (depends on 13)

The method of claim 13, wherein the isomer includes a racemate, an enantiomer, a diastereomer, a mixture of enantiomers or a mixture of diastereomers.

### Claim 15 (depends on 13)

The method of claim 13, wherein the aristoloxazine C is isolated from Asarum heterotropoides roots.

### Claim 16 (depends on 13)

The method of claim 13, wherein the aristoloxazine C, isomer or pharmaceutically acceptable salt thereof exhibits an effect of inhibiting cancer cells or inhibiting or delaying tumor development.

### Claim at position 10

17-20. (canceled)
